A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patterns of resistance to innovation, the importance of genuine public health principles, and the accelerating shift away from combustible cigarettes worldwide. An inspiring call to action for advocates, researchers, consumers, and industry leaders working toward a smoke-free future.
All content for GFN News is the property of GFN.TV and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patterns of resistance to innovation, the importance of genuine public health principles, and the accelerating shift away from combustible cigarettes worldwide. An inspiring call to action for advocates, researchers, consumers, and industry leaders working toward a smoke-free future.
#GFN25 Science Discussion #5 | Association Between HTP Use and Incidence of Respiratory Symptoms
GFN News
16 minutes 34 seconds
1 month ago
#GFN25 Science Discussion #5 | Association Between HTP Use and Incidence of Respiratory Symptoms
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
GFN News
A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patterns of resistance to innovation, the importance of genuine public health principles, and the accelerating shift away from combustible cigarettes worldwide. An inspiring call to action for advocates, researchers, consumers, and industry leaders working toward a smoke-free future.
